Mark A. Wan, 10% Owner at CONCERT PHARMACEUTICALS, INC. (CNCE), bought 107,112 shares at $14.00 ($1.4M) on 2014-02-19, disclosed to the SEC on 2014-02-21.
Open-market purchase of $1.4M CNCE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,612 | $0 | 0.0% |
| 2 | $14.00 | 5,281 | $74K | 5.1% |
| 3 | $14.00 | 98,219 | $1.4M | 94.9% |
| Total | $13.53 avg | 107,112 | $1.4M | 100% |
| Filing → |
| EPOC | SELL | 2011-02-07 | $4.7M | — | Filing → |